CD19-targeting 3rd Generation CAR T Cells

Third-generation anti-CD19 CAR T-cell therapy · Uppsala University

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CD19-targeting 3rd Generation CAR T Cells, covering 2017-10-30 to 2021-10-20. Get the full timeline:

Most recent: Clinical Trial Update: CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy [Phase 2]